Podder S, Masudur Rahman M, Hossain MI, Datta R, Alam J, Golam Kibria M. Efficacy of rifaximin among non-constipated irritable bowel syndrome patients with or without small intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Int J Res Med Sci [Internet]. 2024 Mar. 29 [cited 2025 Nov. 27];12(4):1056-64. Available from: https://www.msjonline.org/index.php/ijrms/article/view/13175